Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Michael Harrison Storandt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1266-7393; OpenAlex author ID A5017352332. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Glucagon-like Peptide-1 Receptor Agonist Use and Pancreatic Cancer Risk in Patients with Chronic Pancreatitis. Co-author DOI 10.3390/cancers18020179↗
  2. Pembrolizumab near the end of life in patients with metastatic pancreatic cancer: a multi-site consecutive series to examine survival and patient treatment bur… Co-author DOI 10.1007/s00262-023-03397-4↗
  3. Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness. First author DOI 10.1200/po.23.00092↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Amit Mahipal · 2 shared papers, 2023–2026 · strength 0.60
  2. Sarina Ailawadi · 1 shared paper, 2026 · strength 0.43
  3. Aminah Jatoi · 1 shared paper, 2023 · strength 0.26
  4. Nguyen H. Tran · 1 shared paper, 2023 · strength 0.26
  5. Júlia C.F. Quintanilha · 1 shared paper, 2023 · strength 0.17
  6. Sakti Chakrabarti · 1 shared paper, 2023 · strength 0.17
  7. Jeffrey S. Ross · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.